Aug 27, 2026 02:20AM
Aug 26, 2026 07:28AM
Aug 25, 2026 04:49PM
Aug 4, 2026 05:51PM
Jul 28, 2026 05:35AM
Jul 13, 2026 06:46AM
Jun 26, 2026 04:09PM Spyre Therapeutics (SYRE) files mixed shelf
Jun 18, 2026 04:00PM
Jun 15, 2026 08:01AM
Jun 4, 2026 04:10AM
Jun 3, 2026 08:03AM
May 5, 2026 04:26PM
May 5, 2026 10:20AM
Apr 13, 2026 04:21PM Raymond James Starts Spyre (SYRE) at Strong Buy, $80 PT
Apr 13, 2026 03:10PM
Apr 13, 2026 02:39PM
Apr 13, 2026 12:37PM
Apr 13, 2026 11:24AM
Apr 13, 2026 10:38AM
Apr 13, 2026 08:45AM
Apr 13, 2026 08:26AM Goldman Sachs on Spyre (SYRE): 'Initial SPY001 efficacy data bolsters confidence into remaining data readouts later this year'
Apr 13, 2026 08:21AM
Apr 13, 2026 07:57AM
Apr 13, 2026 07:54AM
Apr 13, 2026 07:46AM
Apr 13, 2026 07:00AM
Apr 13, 2026 06:56AM
Mar 31, 2026 05:18AM BTIG Reiterates Buy Rating on Spyre (SYRE)
Mar 18, 2026 07:32AM
Mar 16, 2026 11:33AM
Mar 16, 2026 10:39AM
Feb 19, 2026 04:35PM
Jan 12, 2026 08:04AM
Dec 17, 2025 04:04PM
Dec 17, 2025 05:02AM Citi Starts Spyre (SYRE) at Buy
Dec 1, 2025 12:33AM
Nov 5, 2025 07:29AM
Nov 4, 2025 05:50PM
Oct 13, 2025 04:41PM
Oct 7, 2025 05:55AM
Sep 26, 2025 03:27AM
Aug 18, 2025 06:13AM Guggenheim Reiterates Buy Rating on Spyre (SYRE)
Aug 6, 2025 03:16AM
Jun 17, 2025 07:30AM
Jun 4, 2025 06:23AM
Jun 3, 2025 06:20AM
May 8, 2025 04:17PM
Mar 28, 2025 05:24AM
Mar 18, 2025 04:37AM Wolfe Research Starts Spyre (SYRE) at Outperform
Mar 7, 2025 04:43PM

456,658 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All